NewEdge Advisors’s Kura Oncology KURA Stock Holding History

NewEdge Advisors’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.37K	Hold	216	–	–	﹤0.01%	3886
2026 Q1	$1.76K	Buy	+216	New	+$1.86K	﹤0.01%	3830
2023 Q4	–	Sell	-215	Closed	-$1.96K	–	3824
2023 Q3	$1.96K	Hold	215	–	–	﹤0.01%	3053
2023 Q2	$2.27K	Hold	215	–	–	﹤0.01%	3056
2023 Q1	$2.63K	Hold	215	–	–	﹤0.01%	2971
2022 Q4	$3	Buy	+215	New	+$3.13K	﹤0.01%	3901

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NewEdge Advisors's KURA Position: Q2 2026 in Review

NewEdge Advisors held its Kura Oncology (KURA) position steady in Q2 2026 at 216 shares worth $2.37K. The position accounts for ﹤0.01% of the portfolio, ranked #3886.

NewEdge Advisors first reported a position in KURA in Q4 2022 and has held it in 6 quarters since. The position peaked at $2.63K in Q1 2023. 150 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

NewEdge Advisors held 216 shares of Kura Oncology worth $2.37K as of Q2 2026.
NewEdge Advisors left its Kura Oncology share count unchanged in Q2 2026.
Kura Oncology made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #3886 holding.
NewEdge Advisors first reported a position in Kura Oncology in Q4 2022 and has held it in 6 quarters since.
NewEdge Advisors's Kura Oncology position peaked at $2.63K in Q1 2023.
150 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.